investorscraft@gmail.com

Intrinsic Value of Aerie Pharmaceuticals, Inc. (AERI)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %133.5NaN
Revenue, $194NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m240NaN
Operating income, $m-46NaN
EBITDA, $m-9NaN
Interest expense (income), $mNaN
Earnings before tax, $m-74NaN
Tax expense, $m1NaN
Net income, $m-75NaN

BALANCE SHEET

Cash and short-term investments, $m140NaN
Total assets, $m431NaN
Adjusted assets (=assets-cash), $m292NaN
Average production assets, $m53NaN
Working capital, $m231NaN
Total debt, $m239NaN
Total liabilities, $m449NaN
Total equity, $m-17NaN
Debt-to-equity ratio-13.782NaN
Adjusted equity ratio-0.524NaN

CASH FLOW

Net income, $m-75NaN
Depreciation, amort., depletion, $m38NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-99NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-3NaN
Free cash flow, $m-96NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m231
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount